Avai Bio (AVAI) Enterprise Value (2019 - 2023)
Avai Bio's Enterprise Value history spans 4 years, with the latest figure at -$896.0 for Q4 2023.
- For Q4 2023, Enterprise Value rose 95.24% year-over-year to -$896.0; the TTM value through Dec 2023 reached -$896.0, up 95.24%, while the annual FY2023 figure was -$107472.0, N/A changed from the prior year.
- Enterprise Value for Q4 2023 was -$896.0 at Avai Bio, up from -$1480.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$102.0 in Q1 2019 and bottomed at -$107472.0 in Q1 2023.
- The 4-year median for Enterprise Value is -$8598.0 (2020), against an average of -$17430.1.
- The largest annual shift saw Enterprise Value tumbled 26979.41% in 2020 before it skyrocketed 97.69% in 2023.
- A 4-year view of Enterprise Value shows it stood at -$818.0 in 2019, then tumbled by 3508.07% to -$29514.0 in 2020, then surged by 36.26% to -$18812.0 in 2022, then surged by 95.24% to -$896.0 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Enterprise Value are -$896.0 (Q4 2023), -$1480.0 (Q3 2023), and -$518.0 (Q2 2023).